CompletedNot Applicable

Laboratory Outcome Predictors in Coronary Surgery

Brazil87 participantsStarted 2006-01

Plain-language summary

Evaluate less employed markers of tissue hypoperfusion as venoarterial carbon dioxide partial pressure difference (ΔPCO2) and estimated respiratory quotient (eRQ) combined to other classically studied markers as predictive factors of complicated clinical course after cardiac surgery in patients with left ventricular dysfunction.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * adults * left ventricular dysfunction (ejection fraction \< 50%) * patients undergoing coronary artery bypass surgery requiring the use of Cardiopulmonary Bypass (CPB) Exclusion Criteria: * renal failure (creatinine clearance lower than 40 ml/min/m2), * hepatic dysfunction * endocrinologic disorders * pulmonary disease * uncontrolled diabetes mellitus * a history of fever or infection within the week before surgery * previous anemia (hemoglobin ≤ 10.0 g/dL)

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Complicated clinical course after coronary artery bypass surgery

Timeframe: within the first 30 days after surgery

Trial details

NCT IDNCT01178866

SponsorUniversity of Sao Paulo

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2008-01

View on ClinicalTrials.gov More Left Ventricular Dysfunction trials